Skip to main content

Table 1 Patients’ basic characteristics of the two surgical groups

From: Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer

Index

Transurethral needle electrode resection (n = 52)

Transurethral holmium laser resection (n = 51)

Total (n = 103)

P

Age (year) (mean ± sd)

55.8 ± 12.8

58.8 ± 12.9

57.3 ± 12.9

0.236

Gender [n (%)]

    

 Male

34 (65.4)

3 4(66.7)

68 (66.0)

0.891

 Female

18 (34.6)

17 (33.3)

35 (34.0)

Height (cm) (mean ± sd)

166.6 ± 11.2

163.3 ± 10.0

165.0 ± 10.7

0.120

Weight (kg) (mean ± sd)

64.5 ± 14.9

60.4 ± 12.6

62.4 ± 13.9

0.133

BMI (mean ± sd)

23.0 ± 3.8

22.5 ± 3.5

22.8 ± 3.6

0.487

Tumor size (mm) (mean ± sd)

25.7 ± 12.6

25.7 ± 13.9

25.7 ± 13.2

0.998

Tumor size grouping [n (%)]

    

 < 3 cm

37 (71.2)

33 (64.7)

70 (68.0)

0.483

 ≥ 3 cm

15 (28.8)

18 (35.3)

33 (32.0)

Tumor focality [n (%)]

    

 Unifocal

43 (82.7)

43 (84.3)

86 (83.5)

0.825

 Multifocal

9 (17.3)

8 (15.7)

17 (16.5)

Tumor location [n (%)]

    

 Lateral wall

31 (59.6)

31 (60.8)

62 (60.2)

0.993

 Trigone

6 (11.5)

5 (9.8)

11 (10.7)

 Dome

7 (13.5)

7 (13.7)

14 (13.6)

 Posterior wall

3 (5.8)

3 (5.9)

6 (5.8)

 Anterior wall

3 (5.8)

2 (3.9)

5 (4.9)

 Less than 1.5 cm from the ureter mouth

2 (3.8)

3 (5.9)

5 (4.9)

Pathological classification [n (%)]

    

 Ta

33 (63.5)

29 (56.9)

62 (60.2)

0.791

 T1

7 (13.5)

8 (15.7)

15 (14.6)

 Tis

12 (23.1)

14 (27.5)

26 (25.2)

Preoperative tumor grade [n (%)]

    

 G1

44 (84.6)

43 (84.3)

87 (84.5)

1.000

 G2

8 (15.4)

7 (13.7)

15 (14.6)

 G3

0 (0.0)

1 (2.0)

1 (1.0)

Postoperative tumor grade [n (%)]

    

 G1

44 (84.6)

43 (84.3)

87 (84.5)

1.000

 G2

7 (13.5)

7 (13.7)

14 (13.6)

 G3

1 (1.9)

1 (2.0)

2 (1.9)

Comorbid disease [n (%)]

    

 None

30 (57.7)

29 (56.9)

59 (57.3)

1.000

 Diabetes

6 (11.5)

6 (11.8)

12 (11.7)

 High blood pressure

8 (15.4)

7 (13.7)

15 (14.6)

 Coronary heart disease (CHD)

4 (7.7)

5 (9.8)

9 (8.7)

 Prostatic hyperplasia

4 (7.7)

4 (7.8)

8 (7.8)